Srivastava RM - Search Results

1

Immunomodulatory and therapeutic activity of curcumin.

Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. Srivastava RM, et al. Int Immunopharmacol. 2011 Mar;11(3):331-41. doi: 10.1016/j.intimp.2010.08.014. Epub 2010 Sep 8. Int Immunopharmacol. 2011. PMID: 20828642 Review.

2

Immunomodulatory effects of curcumin: in-vivo.

Varalakshmi Ch, Ali AM, Pardhasaradhi BV, Srivastava RM, Singh S, Khar A. Varalakshmi Ch, et al. Among authors: srivastava rm. Int Immunopharmacol. 2008 May;8(5):688-700. doi: 10.1016/j.intimp.2008.01.008. Epub 2008 Feb 13. Int Immunopharmacol. 2008. PMID: 18387511

3

Dendritic cells and their receptors in antitumor immune response.

Srivastava RM, Khar A. Srivastava RM, et al. Curr Mol Med. 2009 Aug;9(6):708-24. doi: 10.2174/156652409788970715. Curr Mol Med. 2009. PMID: 19689298 Review.

4

Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response.

Srivastava RM, Varalakshmi Ch, Khar A. Srivastava RM, et al. Int Immunol. 2007 May;19(5):591-607. doi: 10.1093/intimm/dxm024. Epub 2007 Mar 15. Int Immunol. 2007. PMID: 17369187

5

The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation.

Srivastava RM, Varalakshmi C, Khar A. Srivastava RM, et al. J Immunol. 2008 Jan 15;180(2):1117-30. doi: 10.4049/jimmunol.180.2.1117. J Immunol. 2008. PMID: 18178852

6

Activating and inhibitory receptors and their role in natural killer cell function.

Srivastava RM, Savithri B, Khar A. Srivastava RM, et al. Indian J Biochem Biophys. 2003 Oct;40(5):291-9. Indian J Biochem Biophys. 2003. PMID: 22900322 Review.

7

Utility of bone marrow examination in retinoblastoma and their correlation with hematological features.

Yadav G, Singh A, Kushwaha R, Verma N, Srivastava RM, Singh US. Yadav G, et al. Among authors: srivastava rm. J Med Life. 2023 Aug;16(8):1245-1250. doi: 10.25122/jml-2023-0156. J Med Life. 2023. PMID: 38024824 Free PMC article.

8

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis.

Do MH, Shi W, Ji L, Ladewig E, Zhang X, Srivastava RM, Capistrano KJ, Edwards C, Malik I, Nixon BG, Stamatiades EG, Liu M, Li S, Li P, Chou C, Xu K, Hsu TW, Wang X, Chan TA, Leslie CS, Li MO. Do MH, et al. Among authors: srivastava rm. Immunity. 2023 Nov 14;56(11):2555-2569.e5. doi: 10.1016/j.immuni.2023.10.010. Immunity. 2023. PMID: 37967531

9

Intraocular Pressure Changes While Reading Smartphone Digital Text Versus Printed Text in Healthy Individuals and those with Glaucoma.

Srivastava RM, Agrawal S, Amrin N, Bharti D. Srivastava RM, et al. J Glaucoma. 2024 Mar 1;33(3):189-194. doi: 10.1097/IJG.0000000000002314. Epub 2023 Sep 27. J Glaucoma. 2024. PMID: 37851972

10

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.

Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, Srivastava RM, Ostrovnaya I, Prasad M, Zuur CL, Riaz N, Pfister DG, Klebanoff CA, Chan TA, Ho AL, Morris LGT. Vos JL, et al. Among authors: srivastava rm. Nat Med. 2023 Dec;29(12):3077-3089. doi: 10.1038/s41591-023-02518-x. Epub 2023 Aug 24. Nat Med. 2023. PMID: 37620627 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page